Research location
Móstoles
Madrid, Spain
Advertisement
Research activity in Móstoles
Madrid, SpainCureCurrent currently publishes aggregate city-level research activity for this location: 44 trials and 44 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Móstoles
44 linked trials · page 1 of 1Impact of Virtual Reality Physiotherapy on Multiple Sclerosis PatientsNCT06735053 · 2025-02-01 · 1 site observation
RECRUITING
Observational Study of the Effectiveness of Funded Drugs for Genitourinary Tumors.NCT06724159 · 2024-12-13 · 1 site observation
RECRUITING
A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of RecurrenceNCT06492616 · 2024-09-27 · 1 site observation
RECRUITING
Effects of Home-based Respiratory Muscle Training With New Load Adjustment Test in People With Multiple SclerosisNCT07269054 · 2025-12-12 · 1 site observation
COMPLETED
Symmcora® Long-term Bidirectional Barbed Suture for Anastomosis in Patients Undergoing Robot Assisted Radical ProstatectomyNCT06055946 · 2023-11-07 · 1 site observation
COMPLETED
Risk Stratification Using MEESSI-AHF Scale in ED and Impact on AHF OutcomesNCT05919225 · 2023-06-27 · 1 site observation
UNKNOWN
Impact of Exercise on Ashtma in AdultsNCT05900128 · 2023-06-01 · 1 site observation
COMPLETED
Hemodynamic and Functional Characteristics of the Cerebral Circulation in ObesityNCT06067113 · 2023-05-15 · 1 site observation
UNKNOWN
NeoadjuVAnt muLti-agENT Chemotherapy or Patritumab Deruxtecan With or Without endocrINE Therapy for High-risk HR+/HER2- Breast Cancer - VALENTINE TrialNCT05569811 · 2022-11-25 · 1 site observation
ACTIVE_NOT_RECRUITING
Home-based Transcranial Static Magnetic Field Stimulation (tSMS) of the Supplementary Motor Area in Parkinson's DiseaseNCT06840678 · 2022-10-01 · 1 site observation
UNKNOWN
Three Antidiarrheal Strategies in HER2+/HR+ Early Breast Cancer Patients Treated With Extended Adjuvant NeratinibNCT05252988 · 2022-08-31 · 1 site observation
ACTIVE_NOT_RECRUITING
Anti-SARS-COV2 Vaccination Study in Lung Cancer PatientsNCT05009030 · 2021-05-06 · 1 site observation
COMPLETED
A Study to Evaluate the Efficacy and Safety of Intravenous Prasinezumab in Participants With Early Parkinson's DiseaseNCT04777331 · 2021-05-05 · 1 site observation
ACTIVE_NOT_RECRUITING
A Study to Evaluate the Safety, Tolerability, and Efficacy of Long-Term Gantenerumab Administration in Participants With Alzheimer's Disease (AD)NCT04374253 · 2021-01-26 · 1 site observation
TERMINATED
Hypertonic Saline Therapy in Ambulatory Heart Failure Unit.NCT04533997 · 2021-01-01 · 1 site observation
COMPLETED
Parkinson's Disease (PD) Treated With Focused Ultrasound Subthalamotomy at an Early StageNCT04692116 · 2020-11-25 · 1 site observation
COMPLETED
LunG and Melanoma canceR pAtients coVId19 Disease (GRAVID)NCT04344002 · 2020-04-21 · 1 site observation
COMPLETED
A Feasibility Study on the Safety and Preliminary Efficacy of Bilateral Subthalamotomy Using MRgFUS for Treatment of PDNCT03964272 · 2019-06-18 · 1 site observation
COMPLETED
Evaluation of the Quality of Life of Patients With Metastatic Non-small Cell Lung Cancer With Supplementary Therapy With IGEN-0206NCT04009122 · 2019-06-11 · 1 site observation
COMPLETED
A Study to Evaluate Temporary Blood Brain Barrier Disruption in Patients With Parkinson's Disease DementiaNCT03608553 · 2018-11-26 · 1 site observation
COMPLETED
Study on the Progress of Breast Cancer Cases in Males and the Assessment of Relapse RiskNCT03800355 · 2018-09-14 · 1 site observation
COMPLETED
Efficacy and Safety Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)NCT03444870 · 2018-06-06 · 1 site observation
TERMINATED
A Study to Evaluate the Safety and Efficacy of ExAblate Subthalomotomy for the Treatment of Parkinson's Disease Motor FeaturesNCT03454425 · 2018-02-27 · 1 site observation
COMPLETED
ExAblate Pallidotomy for Medically-Refractory Dyskinesia Symptoms or Motor Fluctuations of Advanced Parkinson's DiseaseNCT03319485 · 2018-02-09 · 1 site observation
ACTIVE_NOT_RECRUITING
Evaluating the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Participants With Parkinson's DiseaseNCT03318523 · 2018-01-10 · 1 site observation
TERMINATED
Nivolumab in the Real World: Analysis of the Expanded Use in Spanish PatientNCT03132493 · 2017-06-01 · 1 site observation
COMPLETED
Observational Study of Obstructive Lung Disease (NOVELTY)NCT02760329 · 2016-07-25 · 1 site observation
COMPLETED
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's PatientsNCT02605434 · 2016-03-01 · 1 site observation
UNKNOWN
Comparison of Pre- and Post-discharge Initiation of LCZ696 Therapy in HFrEF Patients After an Acute Decompensation EventNCT02661217 · 2016-02-12 · 1 site observation
COMPLETED
Participants Preferences to Disease Modifying Agents in Relapsing Remitting Multiple Sclerosis ConditionNCT02598167 · 2015-12-07 · 1 site observation
COMPLETED
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)NCT02657681 · 2015-10-01 · 1 site observation
COMPLETED
Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast CancerNCT02448420 · 2015-07-01 · 1 site observation
COMPLETED
neuroQWERTY: a Transparent Patient-centered Outcome Method to Quantify Parkinsonian Motor Signs for Drug TrialsNCT02522065 · 2015-05-01 · 1 site observation
COMPLETED
A Study of Ipatasertib (GDC-0068) in Combination With Paclitaxel as Neoadjuvant Treatment for Participants With Early Stage Triple Negative Breast CancerNCT02301988 · 2015-02-17 · 1 site observation
COMPLETED
Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection FractionNCT02226120 · 2014-10-16 · 1 site observation
COMPLETED
Phase II Study of SBRT as Treatment for Oligometastases in Prostate CancerNCT02192788 · 2014-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection FractionNCT01920711 · 2014-07-18 · 1 site observation
COMPLETED
Multicenter Descriptive Study of the Patient Clinical Profile That Begins With Disseminated Her 2 + Breast Cancer or Develops a Metastasis After or During the Adjuvant TherapyNCT01645059 · 2011-07-01 · 1 site observation
COMPLETED
This Study Will Evaluate the Efficacy and Safety of LCZ696 Compared to Enalapril on Morbidity and Mortality of Patients With Chronic Heart FailureNCT01035255 · 2009-12-01 · 1 site observation
TERMINATED
Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With SchizophreniaNCT00206128 · 2004-11-01 · 1 site observation
COMPLETED
Antiretroviral Treatment Simplification Study With Efavirenz + Abacavir + 3TC Once DailyNCT00314626 · 2004-11-01 · 1 site observation
COMPLETED
FAC Versus FAC Plus Weekly Paclitaxel as Adjuvant Treatment of Node Negative High Risk Breast Cancer PatientsNCT00129389 · 2003-09-19 · 1 site observation
COMPLETED
Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast CancerNCT00129922 · 1999-11-01 · 1 site observation
COMPLETED
Named Patient Use Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast CancerNCT03763604 · 1 site observation
APPROVED_FOR_MARKETING
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.